23 May 2025 Report on the EU Carbon Border Adjustment Mechanism: A review of the EU CBAM’s economic principles, expected impacts and outstanding issues Energy
12 May 2025 Compass Lexecon Clients Microsoft and Activision Prevail in FTC’s Appeal of Landmark Merger Case Entertainment & Media
05 May 2025 Mondi expands with €634 million acquisition of Schumacher Packaging’s Western Europe assets Manufacturing
Insights Healthcare & Life Sciences Search Search insight Filters Type Type… News Publications Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Antitrust & Competition: Damages Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences Healthcare & Life Sciences Clear all Showing 1–4 of 4 results News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry Article • 05 Dec 2011 The Economic Benefits of Pharmacy Benefit Managers - J. Orszag & K. Green Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients
News • 08 Jan 2025 Leading IO and Health Care Economist Professor Matthew Grennan Affiliates with Compass Lexecon
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 30 Oct 2002 Lexecon Economist Quoted in New York Times Article, Hospitals Battle For-Profit Groups for Patients